NDC 44911-0313

Influenzinum 2015-2016

Influenzinum

Influenzinum 2015-2016 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Influenza A Virus A/brisbane/10/2010 (h1n1) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/brisbane/10/2010 (h1n1) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/south Australia/55/2014 (h3n2) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/south Australia/55/2014 (h3n2) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza B Virus B/utah/9/2014 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated); Influenza B Virus B/utah/9/2014 Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated).

Product ID44911-0313_6f92f885-3688-4c32-bb74-c6f635653c68
NDC44911-0313
Product TypeHuman Otc Drug
Proprietary NameInfluenzinum 2015-2016
Generic NameInfluenzinum
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2015-12-16
Marketing End Date2021-01-26
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameEnergique, Inc.
Substance NameINFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 (H3N2) NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/UTAH/9/2014 NEURAMINIDASE ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
Active Ingredient Strength200 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
NDC Exclude FlagN

Packaging

NDC 44911-0313-1

30 mL in 1 BOTTLE, DROPPER (44911-0313-1)
Marketing Start Date2015-12-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44911-0313-1 [44911031301]

Influenzinum 2015-2016 LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-16
Marketing End Date2021-01-26

Drug Details

Active Ingredients

IngredientStrength
INFLUENZA A VIRUS A/BRISBANE/10/2010 (H1N1) HEMAGGLUTININ ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)200 [hp_C]/mL

OpenFDA Data

SPL SET ID:b3aa8d2c-d7ea-466b-97c0-431359d97b9b
Manufacturer
UNII

NDC Crossover Matching brand name "Influenzinum 2015-2016" or generic name "Influenzinum"

NDCBrand NameGeneric Name
44911-0313Influenzinum 2015-2016Influenzinum
15631-0235INFLUENZINUMINFLUENZINUM
43406-0093InfluenzinumInfluenzinum
60512-7126INFLUENZINUMINFLUENZINUM

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.